KYTX — Kyverna Therapeutics Share News
0.000.00%
Last trade - 00:00- $354.36m
- $179.94m
Brief: Kyverna Therapeutics Announces Positive Primary Analysis Results From KYSA-8 Trial Of Miv-Cel In SPS
Brief: Kyverna Therapeutics Enters Open Market Sale Agreement With Jefferies Dated March 27, 2025 - SEC Filing
Brief: Kyverna Therapeutics Appoints Biotech Leaders Sravan Emany And Andrew Miller To Board Of Directors
Brief: Kyverna Therapeutics Inc - Appoints Christi Shaw As Executive Chairperson - SEC Filing
Brief: Kyverna Therapeutics Provides Corporate Update And Outlines 2026 Strategic Priorities At The J.P. Morgan Healthcare Conference
U.S. STOCKS ON THE MOVE-Robinhood Markets, Cannabis stocks, Hyatt Hotels
U.S. STOCKS ON THE MOVE-Spotify, Robinhood Markets, Cannabis stocks
Brief: Kyverna Therapeutics Announces Pricing Of $100 Million Public Offering
Kyverna Therapeutics tumbles on deep-discounted $100 mln stock deal
Kyverna Therapeutics falls on $100 mln stock sale plans
Brief: Kyverna Therapeutics Announces Proposed Public Offering Of Common Stock
U.S. STOCKS ON THE MOVE-Brystol Myers, Nvidia
U.S. STOCKS ON THE MOVE-Vanda Pharma, Tesla, Zillow
Kyverna jumps after cell therapy meets main goal of mid-stage study
NASDAQ RESUMED AT 09:59 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:54 AM
U.S. STOCKS ON THE MOVE-Micron Technology, Carvana, ServiceNow
U.S. STOCKS ON THE MOVE-Dollar General, Rocket Lab, Applied Materials
Kyverna jumps after cell therapy meets main goal of mid-stage study